Select Page

Medicxi pioneers ‘exit and reinvest’ for biotech sector with €200m close of debut secondaries fund

Medicxi pioneers ‘exit and reinvest’ for biotech sector with €200m close of debut secondaries fund


European life sciences investor Medicxi has hit a €200m final close for its debut secondaries fund amid using the vehi



Source link

About The Author

Leave a reply

Your email address will not be published. Required fields are marked *